BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 12358756)

  • 1. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
    Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
    J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
    Cumbay MG; Watts VJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1201-9. PubMed ID: 11356947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-induced alterations in cyclic AMP signaling in the Cath.a differentiated (CAD) neuronal cell line.
    Johnston CA; Beazely MA; Bilodeau ML; Andrisani O; Watts VJ
    J Neurochem; 2004 Mar; 88(6):1497-508. PubMed ID: 15009651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.
    Watts VJ; Wiens BL; Cumbay MG; Vu MN; Neve RL; Neve KA
    J Neurosci; 1998 Nov; 18(21):8692-9. PubMed ID: 9786976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptor-induced heterologous sensitization of adenylyl cyclase requires Galphas: characterization of Galphas-insensitive mutants of adenylyl cyclase V.
    Watts VJ; Taussig R; Neve RL; Neve KA
    Mol Pharmacol; 2001 Dec; 60(6):1168-72. PubMed ID: 11723222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells.
    Lambert HW; Weiss ER; Lauder JM
    Dev Neurosci; 2001; 23(1):70-7. PubMed ID: 11173928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.
    Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH
    PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic agonists induce heterologous sensitization of adenylate cyclase in NS20Y-D(2L) cells.
    Johnston CA; Cumbay MG; Vortherms TA; Watts VJ
    FEBS Lett; 2001 May; 497(2-3):85-9. PubMed ID: 11377418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
    Vortherms TA; Watts VJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta.
    Linde C; Quast U
    Br J Pharmacol; 1995 Jun; 115(3):515-21. PubMed ID: 7582466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform.
    Thomas JM; Hoffman BB
    Mol Pharmacol; 1996 May; 49(5):907-14. PubMed ID: 8622641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors.
    Watts VJ; Vu MN; Wiens BL; Jovanovic V; Van Tol HH; Neve KA
    Psychopharmacology (Berl); 1999 Jan; 141(1):83-92. PubMed ID: 9952069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
    Murthy KS; Zhou H; Makhlouf GM
    Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic 3',5'-adenosine monophosphate mediates dopamine D1-stimulated growth hormone release from goldfish pituitary cells.
    Wong AO; van der Kraak G; Chang JP
    Neuroendocrinology; 1994 Oct; 60(4):410-7. PubMed ID: 7529899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opposite effects of cyclic AMP-protein kinase a signal transduction pathway on renal cortical and medullary Na+,K+-ATPase activity.
    Bełtowski J; Marciniak A; Wójcicka G; Górny D
    J Physiol Pharmacol; 2002 Jun; 53(2):211-31. PubMed ID: 12120897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor inhibition of adenylyl cyclase is abolished by acute ethanol but restored after chronic ethanol exposure (tolerance).
    Yao L; Asai K; Jiang Z; Ishii A; Fan P; Gordon AS; Diamond I
    J Pharmacol Exp Ther; 2001 Aug; 298(2):833-9. PubMed ID: 11454949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone secretion by luteinizing human granulosa cells: a possible cAMP-dependent but PKA-independent mechanism involved in its regulation.
    Chin EC; Abayasekara DR
    J Endocrinol; 2004 Oct; 183(1):51-60. PubMed ID: 15525573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1997 Aug; 52(2):181-6. PubMed ID: 9271339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.